Evidence map›Paper›PMID 42470578›Full record

ArticleJapanese journal of ophthalmology2026

Corrected gestational age-specific prediction models for identifying treatment-requiring retinopathy of prematurity.

Sao Sugimoto, Masako Nagahara, Kentaro Hayashi, Takuya Kuriyama, Han Peng Zhou, Gen Mihara, Kosuke Nakajima, Takashi Ueta, Taku Toyama

Abstract read
PubMed Publisher
In one paragraph

Article in Japanese journal of ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sao SugimotoDepartment of Ophthalmology, The University of Tokyo Hospital, Tokyo, Japan.
Masako NagaharaDepartment of Ophthalmology, The University of Tokyo Hospital, Tokyo, Japan.
Kentaro HayashiDepartment of Ophthalmology, The University of Tokyo Hospital, Tokyo, Japan.
Takuya KuriyamaDepartment of Ophthalmology, The University of Tokyo Hospital, Tokyo, Japan.
Han Peng ZhouDepartment of Ophthalmology, The University of Tokyo Hospital, Tokyo, Japan.
Gen MiharaDepartment of Ophthalmology, The University of Tokyo Hospital, Tokyo, Japan.
Kosuke NakajimaDepartment of Ophthalmology, The University of Tokyo Hospital, Tokyo, Japan.
Takashi UetaDepartment of Ophthalmology, The University of Tokyo Hospital, Tokyo, Japan.
Taku ToyamaDepartment of Ophthalmology, The University of Tokyo Hospital, Tokyo, Japan. toyama.ophthalmol@gmail.com.ORCID http://orcid.org/0009-0001-0388-0635

Funding

Japan Society for the Promotion of Science 22K16963
6 · The paper itself

Abstract

purposeTo develop and validate time-updated, corrected gestational age (CGA)-specific prediction models for identifying treatment-requiring retinopathy of prematurity (ROP) using routinely available systemic factors, and to assess longitudinal changes in predictor combinations and model performance with advancing CGA. STUDY

designRetrospective cohort study.

methodsPreterm infants who met institutional ROP screening criteria from a single tertiary center were included, excluding those with aggressive ROP. Multivariable logistic regression models were independently developed at CGA 28, 30, 32, and 34 weeks using routinely available systemic variables summarized from birth to each CGA. For each CGA-specific analysis, infants treated before the target CGA were excluded. Exhaustive subset selection based on the Akaike information criterion identified CGA-specific optimal predictor sets. Model performance was evaluated using stratified five-fold cross-validation with out-of-fold predictions, and discrimination was assessed by the area under the receiver operating characteristic curve (AUC).

resultsPredictor combinations selected by the optimal models differed across CGAs, indicating longitudinal changes in the predictive relevance of systemic factors. Growth-related and inflammatory indices were repeatedly selected, while overall predictor composition evolved with advancing CGA. Discrimination improved at later CGAs, with cross-validated AUCs of 0.650, 0.716, 0.809, and 0.842 at CGA 28, 30, 32, and 34 weeks, respectively.

conclusionThese findings suggest that CGA-specific prediction models may help characterize the evolving risk of treatment-requiring ROP. However, prospective multicenter validation and further refinement are required before clinical application.

Indexed as

Corrected gestational ageInflammatory markersPostnatal growthPrediction modelRetinopathy of prematurity

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.